Published in Annu Rev Nutr on January 01, 2015
Comparison of the DASH (Dietary Approaches to Stop Hypertension) diet and a higher-fat DASH diet on blood pressure and lipids and lipoproteins: a randomized controlled trial. Am J Clin Nutr (2015) 1.42
Regular-Fat Dairy and Human Health: A Synopsis of Symposia Presented in Europe and North America (2014-2015). Nutrients (2016) 0.79
DNA methylation landscape of fat deposits and fatty acid composition in obese and lean pigs. Sci Rep (2016) 0.78
Dietary Fatty Acids and Changes in Blood Lipids during Adolescence: The Role of Substituting Nutrient Intakes. Nutrients (2017) 0.75
Setting the Lipid Component of the Diet: A Work in Process. Adv Nutr (2017) 0.75
Cardiometabolic Syndrome and Increased Risk of Heart Failure. Curr Heart Fail Rep (2016) 0.75
Full fat milk consumption protects against severe childhood obesity in Latinos. Prev Med Rep (2017) 0.75
Nutrition, inflammation and cancer. Nat Immunol (2017) 0.75
Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med (2013) 20.98
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med (2014) 12.79
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44
Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med (2009) 12.38
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med (2013) 9.44
Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA (2012) 9.37
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation (1999) 8.13
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest (2009) 7.09
Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern Med (2014) 7.08
Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA (2005) 6.89
Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr (2003) 6.83
Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67
Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med (2010) 5.86
Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79
Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation (2010) 5.58
The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) (2008) 5.50
n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr (2006) 5.43
Effects of low-carbohydrate and low-fat diets: a randomized trial. Ann Intern Med (2014) 5.31
Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res (2008) 4.88
Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr (2010) 4.85
A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med (2009) 4.80
Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med (2010) 4.79
Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA (2012) 4.33
Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med (2006) 4.19
Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med (2006) 4.16
Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr (2010) 3.99
Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr (1999) 3.91
Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr (2009) 3.90
Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am J Clin Nutr (2006) 3.86
Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia (2001) 3.73
Major dietary protein sources and risk of coronary heart disease in women. Circulation (2010) 3.65
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 3.35
Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res (2002) 3.23
Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb (1992) 3.15
n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr (2010) 3.09
Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol (2014) 3.00
Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation (2014) 2.95
Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study. Circulation (2012) 2.90
Components of a cardioprotective diet: new insights. Circulation (2011) 2.81
Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol (1998) 2.74
The effect of a plant-based low-carbohydrate ("Eco-Atkins") diet on body weight and blood lipid concentrations in hyperlipidemic subjects. Arch Intern Med (2009) 2.68
Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study. Circulation (2014) 2.63
The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials (2011) 2.59
Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA (2014) 2.59
Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med (2012) 2.58
Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med (2010) 2.48
Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev (2012) 2.47
Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr (2010) 2.46
Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr Rev (2006) 2.38
Caloric sweetener consumption and dyslipidemia among US adults. JAMA (2010) 2.30
Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol (2002) 2.23
Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med Scand Suppl (1966) 2.20
Glycemic response and health--a systematic review and meta-analysis: relations between dietary glycemic properties and health outcomes. Am J Clin Nutr (2008) 2.14
Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr (2009) 2.07
Mechanisms for the acute effect of fructose on postprandial lipemia. Am J Clin Nutr (2007) 2.04
Diets high in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. Am J Clin Nutr (2011) 2.04
Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am J Clin Nutr (2010) 2.01
Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol. Am J Clin Nutr (2005) 1.98
The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids (2010) 1.96
Dietary protein, weight loss, and weight maintenance. Annu Rev Nutr (2009) 1.96
Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr (2004) 1.94
Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr (2004) 1.93
Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women. J Clin Endocrinol Metab (2011) 1.89
Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trial. Circulation (2011) 1.88
Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol (2014) 1.87
Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. J Am Coll Cardiol (2006) 1.84
Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Arterioscler Thromb Vasc Biol (2009) 1.83
Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids (2010) 1.75
Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2012) 1.71
Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr (2013) 1.70
Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation (2006) 1.69
The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am J Clin Nutr (2011) 1.66
Diets containing high amylose vs amylopectin starch: effects on metabolic variables in human subjects. Am J Clin Nutr (1989) 1.65
Meat intake and cause-specific mortality: a pooled analysis of Asian prospective cohort studies. Am J Clin Nutr (2013) 1.61
Long term weight maintenance after advice to consume low carbohydrate, higher protein diets--a systematic review and meta analysis. Nutr Metab Cardiovasc Dis (2013) 1.60
Dairy calcium intake modifies responsiveness of fat metabolism and blood lipids to a high-fat diet. Br J Nutr (2011) 1.59
Dietary fatty acids and cardiovascular disease: an epidemiological approach. Prog Lipid Res (2008) 1.58
Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr (2008) 1.57
Dietary sugars and cardiometabolic risk: systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids. Am J Clin Nutr (2014) 1.56
Dietary intake of saturated fatty acids and incident stroke and coronary heart disease in Japanese communities: the JPHC Study. Eur Heart J (2013) 1.55
The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol (2006) 1.55
Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int J Cardiol (2012) 1.54
Dietary fatty acids and risk of coronary heart disease in men: the Kuopio Ischemic Heart Disease Risk Factor Study. Arterioscler Thromb Vasc Biol (2014) 1.48
Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids (2007) 1.45
Low-carbohydrate nutrition and metabolism. Am J Clin Nutr (2007) 1.42
'Mediterranean' dietary pattern for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2013) 1.40
Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans--a quantitative review. PLoS One (2010) 1.39
Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. Am J Clin Nutr (2010) 1.39
Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab (2009) 1.36
Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies. Eur J Clin Nutr (2004) 1.36
Postprandial response of adiponectin, interleukin-6, tumor necrosis factor-alpha, and C-reactive protein to a high-fat dietary load. Nutrition (2008) 1.35
Dietary intake of saturated fat by food source and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr (2012) 1.32
Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am J Clin Nutr (2010) 1.31
Effects of saturated and polyunsaturated fat diets on the chemical composition and metabolism of low density lipoproteins in man. J Lipid Res (1980) 1.30
Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index. J Am Coll Nutr (1998) 1.29
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature (2010) 12.07
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med (2013) 9.44
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest (2009) 7.09
Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet (2009) 6.79
Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr (2010) 4.85
Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am J Hum Genet (2008) 3.61
Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res (2002) 3.23
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev (2006) 2.99
Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiol (2006) 2.94
Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92
Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol (2005) 2.80
Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet (2002) 2.71
Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr (2010) 2.46
A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. Nature (2013) 2.46
Genome-wide association of lipid-lowering response to statins in combined study populations. PLoS One (2010) 2.43
American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract (2003) 2.42
Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A (2004) 2.41
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol (2006) 2.41
HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin Chem (2011) 2.33
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov (2007) 2.32
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit Pathw Cardiol (2005) 2.31
Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J Lipid Res (2002) 2.28
Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis. Clin Chem (2008) 2.27
Differential effects of ramipril on ambulatory blood pressure in African Americans and Caucasians. Am J Hypertens (2007) 2.06
Pharmacogenomics: challenges and opportunities. Ann Intern Med (2006) 1.96
Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ Cardiovasc Genet (2008) 1.89
When good drugs go bad. Nature (2007) 1.85
Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Arterioscler Thromb Vasc Biol (2009) 1.83
A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. J Lipid Res (2008) 1.79
Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease. J Gastroenterol Hepatol (2012) 1.67
The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am J Clin Nutr (2011) 1.66
Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin. Circulation (2008) 1.64
Tracing sub-structure in the European American population with PCA-informative markers. PLoS Genet (2008) 1.56
RHOA is a modulator of the cholesterol-lowering effects of statin. PLoS Genet (2012) 1.54
Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet (2011) 1.51
High-density lipoproteins: a consensus statement from the National Lipid Association. J Clin Lipidol (2013) 1.50
Evidence for impaired lipolysis in abdominally obese men: postprandial study of apolipoprotein B-48- and B-100-containing lipoproteins. Am J Clin Nutr (2002) 1.49
Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. Br J Nutr (2008) 1.38
A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk. Eur J Nutr (2009) 1.38
Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans. Genet Med (2003) 1.38
Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab (2005) 1.37
Enteric microbiome metabolites correlate with response to simvastatin treatment. PLoS One (2011) 1.31
Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study. Metabolomics (2010) 1.29
Reversal of small, dense LDL subclass phenotype by normalization of adiposity. Obesity (Silver Spring) (2009) 1.28
Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein. Nat Chem Biol (2012) 1.27
Saturated fatty acids and risk of coronary heart disease: modulation by replacement nutrients. Curr Atheroscler Rep (2010) 1.23
A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT. Pharmacogenet Genomics (2012) 1.23
Protein in optimal health: heart disease and type 2 diabetes. Am J Clin Nutr (2008) 1.22
Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment. PLoS One (2012) 1.22
Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice. J Lipid Res (2002) 1.19
Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin. Arterioscler Thromb Vasc Biol (2010) 1.19
Smallest LDL particles are most strongly related to coronary disease progression in men. Arterioscler Thromb Vasc Biol (2003) 1.17
Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins. Proc Natl Acad Sci U S A (2008) 1.15
Coordinately regulated alternative splicing of genes involved in cholesterol biosynthesis and uptake. PLoS One (2011) 1.14
Endothelial lipase is associated with inflammation in humans. J Lipid Res (2006) 1.12
Use of an electronic medical record to characterize cases of intermediate statin-induced muscle toxicity. Prev Cardiol (2009) 1.11
Hepatic nuclear factor 1-alpha: inflammation, genetics, and atherosclerosis. Curr Opin Lipidol (2009) 1.09
Characterization of low-density lipoprotein cholesterol-lowering efficacy for atorvastatin in a population-based DNA biorepository. Basic Clin Pharmacol Toxicol (2008) 1.09
VLDL hydrolysis by LPL activates PPAR-alpha through generation of unbound fatty acids. J Lipid Res (2010) 1.08
Individualized hormone-replacement therapy? N Engl J Med (2002) 1.08
Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia. Circ Res (2004) 1.07
Characterization of epistasis influencing complex spontaneous obesity in the BSB model. Genetics (2004) 1.07
Cardiovascular pharmacogenomics. Circ Res (2011) 1.03
Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell lines. Pharmacogenomics (2014) 1.00
Apolipoprotein C-III isoforms: kinetics and relative implication in lipid metabolism. J Lipid Res (2006) 1.00
Role of CYP27A in cholesterol and bile acid metabolism. J Lipid Res (2004) 0.99
Multi-ethnic analysis of lipid-associated loci: the NHLBI CARe project. PLoS One (2012) 0.98
Pharmacogenomics of statin response. Curr Opin Mol Ther (2008) 0.97
Association between angiotensinogen, angiotensin II receptor genes, and blood pressure response to an angiotensin-converting enzyme inhibitor. Circulation (2007) 0.97
Multivariate methods and software for association mapping in dose-response genome-wide association studies. BioData Min (2012) 0.96
A common polymorphism in the LDL receptor gene has multiple effects on LDL receptor function. Hum Mol Genet (2013) 0.96
Low-density lipoprotein particle size loci in familial combined hyperlipidemia: evidence for multiple loci from a genome scan. Arterioscler Thromb Vasc Biol (2004) 0.96
The role of HMGCR alternative splicing in statin efficacy. Trends Cardiovasc Med (2009) 0.96
Lack of effect of dietary conjugated linoleic acids naturally incorporated into butter on the lipid profile and body composition of overweight and obese men. Am J Clin Nutr (2005) 0.96
Polymorphisms in the peroxisome proliferator activated receptor alpha gene are associated with levels of apolipoprotein CIII and triglyceride in African-Americans but not Caucasians. Atherosclerosis (2007) 0.96
Fatty acid desaturase regulation in adipose tissue by dietary composition is independent of weight loss and is correlated with the plasma triacylglycerol response. Am J Clin Nutr (2007) 0.96
Pharmacogenomics of statin response. Curr Opin Lipidol (2007) 0.95
ATHENA: a tool for meta-dimensional analysis applied to genotypes and gene expression data to predict HDL cholesterol levels. Pac Symp Biocomput (2013) 0.95
Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet. J Lipid Res (2010) 0.95
Behavioral versus genetic correlates of lipoproteins and adiposity in identical twins discordant for exercise. Circulation (2005) 0.94
Influence of dietary carbohydrate and fat on LDL and HDL particle distributions. Curr Atheroscler Rep (2005) 0.92
Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals. J Clin Endocrinol Metab (2015) 0.92
Epistatic interaction between two nonstructural loci on chromosomes 7 and 3 influences hepatic lipase activity in BSB mice. J Lipid Res (2004) 0.92
ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan. J Lipid Res (2002) 0.91
Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons. Hum Mol Genet (2004) 0.91
Visceral adiposity and endothelial lipase. J Clin Endocrinol Metab (2006) 0.91
Identification of a congenic mouse line with obesity and body length phenotypes. Mamm Genome (2004) 0.91
Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia. Atherosclerosis (2011) 0.91
Postprandial hyperlipidemia: another correlate of the "hypertriglyceridemic waist" phenotype in men. Atherosclerosis (2003) 0.90
Levels of cholesterol in small LDL particles predict atherosclerosis progression and incident CHD in the HDL-Atherosclerosis Treatment Study (HATS). PLoS One (2013) 0.90
Development and validation of a scale for rating motor compensations used for reaching in patients with hemiparesis: the reaching performance scale. Phys Ther (2004) 0.89
Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men. Atherosclerosis (2010) 0.89
Genetic nondiscrimination legislation: a critical prerequisite for pharmacogenomics data sharing. Pharmacogenomics (2007) 0.89
High disaccharide intake associates with atherogenic lipoprotein profile. Br J Nutr (2011) 0.89
A novel mouse Chromosome 2 congenic strain with obesity phenotypes. Mamm Genome (2004) 0.89